Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.94 -0.20 (-0.77%)
At close: Oct 20, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) posted Depreciation & Amortization (CF) of $8.04 million for Q2 2026, down 3.7% from $8.35 million a year earlier and down 0.4% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Amphastar Pharmaceuticals was $32.05 million, down 2.2% year-over-year; for FY2025, it was $31.65 million, up 12.0% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for seven consecutive years, with a five-year compound annual growth rate of 28.5% (FY2020 to FY2025).
  • In prior years, Amphastar Pharmaceuticals' Depreciation & Amortization (CF) was $28.25 million in FY2024 (+9.8%), $25.74 million in FY2023 (+104.3%), $12.6 million in FY2022 (+23.2%) and $10.23 million in FY2021 (+13.2%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $2.5 million in Q3 2021 to a high of $9.79 million in Q3 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in three of the last eight quarters, with an average decline of 7.9%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2024, with growth of 215.9%; the weakest was Q4 2024, with a decline of 24.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $8.08 million (Q1 2026), $8.07 million (Q4 2025) and $7.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 1.96 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 194.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.93 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 1.62 Bn
10 Amphastar Pharmaceuticals 1.13 Bn -10.28 Mn 93.47 Mn 8.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.04 Mn
Mar 31, 2026 8.08 Mn
Dec 31, 2025 8.07 Mn
Sep 30, 2025 7.86 Mn
Jun 30, 2025 8.35 Mn
Mar 31, 2025 7.37 Mn
Dec 31, 2024 7.26 Mn
Sep 30, 2024 9.79 Mn
Jun 30, 2024 9.68 Mn
Mar 31, 2024 9.66 Mn
Dec 31, 2023 9.66 Mn
Sep 30, 2023 9.62 Mn
Jun 30, 2023 3.06 Mn
Mar 31, 2023 3.40 Mn
Dec 31, 2022 3.44 Mn
Sep 30, 2022 3.42 Mn
Jun 30, 2022 3.00 Mn
Mar 31, 2022 2.74 Mn
Dec 31, 2021 2.60 Mn
Sep 30, 2021 2.50 Mn
API Access

Amphastar Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMPH&period=max&api_key=YOUR_API_KEY